Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Dejan Đokanović"'
Autor:
Dejan Đokanović, Radoslav Gajanin, Zdenka Gojković, Goran Marošević, Igor Sladojević, Vesna Gajanin, Olja Jović-Đokanović, Ljiljana Amidžić
Publikováno v:
Current Oncology, Vol 30, Iss 4, Pp 4289-4300 (2023)
Background: Various factors can affect the survival of patients with laryngeal cancer (LC). In this retrospective study, we assessed clinicopathological features, their prognostic value, and treatment modalities for patients with confirmed squamous c
Externí odkaz:
https://doaj.org/article/7e48a9b8502347378094407b87b25a29
Autor:
Jelena Berendika, Saša Jungić, Biljana Tubić, Ivanka Rakita, Milka Vještica, Dejan Đokanović, Zdenka Gojković, Nikolina Mirčeta, Sanja Petković, Vanda Marković-Peković
Publikováno v:
Scripta Medica. 53:29-35
Background / Aim: Up until ten years ago stage four melanoma was considered a disease with extremely poor prognosis. Standard therapy during this period of time was dacarbazine chemotherapy. Patients with better performance status were treated with i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::129179c955b47926731c51aa87b6e68f
https://doi.org/10.5937/scriptamed53-35184
https://doi.org/10.5937/scriptamed53-35184
Publikováno v:
Scripta Medica. 49:43-48
Introduction: Testicular tumors account for approximately 1% of all malignancies in men, but the age of patients and its increasing incidence make this malignancy one of the leading oncological problems. In spite of the fact that the testicles are or
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::12732b18b67ca09189f0104825cca18c
https://doi.org/10.18575/msrs.sm.e.18.07
https://doi.org/10.18575/msrs.sm.e.18.07
Autor:
Branislava Jakovljevic, Zdenka Gojkovic, Ivanka Rakita, Sasa Jungic, Marina Štrbac, Dejan Đokanović, Siniša Maksimović, Milka Vjestica, Radmila Raseta, Živko Vranješ
Publikováno v:
SCRIPTA MEDICA. 49
Introduction: The introduction of BRAF inhibitor vemurafenib significantly improvedoverall survival (OS) in metastatic melanoma patients.Aim of the Study: The purpose of this study was to determine OS and progressionfree survival (PFS) in patients wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d2ab89d2ed0379a1ee684484ed8154e2
https://doi.org/10.7251/scmed1802126g
https://doi.org/10.7251/scmed1802126g
Autor:
Vladimir Krivokuca, Anđa Škobić, Dejan Ćazić, Branislava Golub Jakovljevic, Dejan Đokanović, Snježana Milićević
Publikováno v:
International Journal of Research in Medical Sciences. 5:5443
Cancer of the testis is a relatively uncommon disease, accounting for approximately 1-1.5% of all cancers in males. 5% of the malignant germ cell tumors are made of extragonadal origin. Germ cell tumors occur in men younger, usually between 20 and 35
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cdec5ee35b6ba099b1e2954dbea3c910
https://doi.org/10.18203/2320-6012.ijrms20175470
https://doi.org/10.18203/2320-6012.ijrms20175470